Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gainers

• Cadrenal Therapeutics, Inc. CVKD shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.
• Healthcare Triangle, Inc. HCTI shares gained 64.7% to $5.37 in pre-market trading after adding over 8% on Tuesday.
• FLJ Group Limited FLJ shares rose 27.1% to $0.3661 in pre-market trading after declining around 5% on Tuesday.
• Enochian Biosciences Inc. ENOB shares rose 26.4% to $0.6321 in pre-market trading. On July 7, 2023, Enochian Biosciences received a deficiency notice from the Nasdaq Stock Market informing the company that its common stock, par value $0.0001 per share, failed to comply with the $1 minimum bid price.
• Eloxx Pharmaceuticals, Inc. ELOX gained 22.7% to $9.30 in pre-market trading. Eloxx Pharmaceuticals shares jumped 94% on Tuesday after Oppenheimer raised its price target from $50 to $55.
• Vivos Therapeutics, Inc. VVOS gained 10.3% to $0.57 in pre-market trading.
• Data Storage Corporation DTST rose 9.8% to $2.79 in pre-market trading. Data Storage recently reported a large, subscription-based contract with a leading promotional products company.
• CBL International Limited BANL rose 9.1% to $5.44 in pre-market trading after jumping over 12% on Tuesday.
• Ascent Solar Technologies, Inc. ASTI shares climbed 8% to $0.1242 in pre-market trading. Ascent Solar Technologies recently reported bridge financing of up to 900 series 1B convertible preferred shares for $1,000 per share for aggregate gross proceeds of $900,000.
• ImmuCell Corporation ICCC shares gained 4.2% to $5.19 in pre-market trading. ImmuCell reported preliminary sales of $3.53 million for the second quarter, down from $3.86 million in the previous year.

Losers

• Silk Road Medical, Inc SILK fell 22.1% to $25.43 in pre-market trading. Silk Road Medical is expected to report financial results for the second quarter 2023 on Aug. 1, 2023. JP Morgan downgraded Silk Road Medical from Overweight to Neutral and lowered the price target from $50 to $28.
• ShiftPixy, Inc. PIXY fell 20.9% to $1.89 in pre-market trading.
• PainReform Ltd. PRFX fell 19.2% to $13.33 in pre-market trading after jumping 307% on Tuesday.
• Biodexa Pharmaceuticals Plc BDRX fell 12.9% to $5.25 in pre-market trading after surging 42% on Tuesday.
• Adial Pharmaceuticals, Inc. ADIL shares fell 11.4% to $0.3411 in pre-market trading. Adial Pharmaceuticals shares jumped 90% on Tuesday after the company provided business update following favorable comments from US, EU regulatory meetings.
• WANG & LEE GROUP, Inc. WLGS shares fell 11% to $1.38 in pre-market trading after rising over 20% on Tuesday.
• CytoMed Therapeutics Limited GDTC shares dropped 9.8% to $5.09 in pre-market trading after climbing 62% on Tuesday.
• Cingulate Inc. CING fell 9.4% to $0.77 in pre-market trading. Cingulate recently announced top-line results from its Phase 3 adult efficacy and safety trial of CTx-1301 for ADHD.
• Crown ElectroKinetics Corp. CRKN fell 7.3% to $0.1009 in pre-market after gaining around 7% on Tuesday.
• Purple Biotech Ltd. PPBT fell 6.2% to $1.29 in pre-market trading. Purple Biotech recently reported results of CM24 dose escalation in advanced pancreatic cancer patients.

Now Read This: Investor Optimism Improves Ahead Of Inflation Data